Highest-materiality recent filing
RadNet shareholders approve all four proposals at 2026 annual meeting
Six directors elected; highest 'For' votes: 64.4M (Sorensen), lowest: 56.9M (Jacobs). Broker non-votes 8.1M each.
RadNet announces proposed $200M incremental term loan for acquisitions and growth
Seeks $200 million incremental term loan under existing credit agreement, maturing April 18, 2031.
RadNet Q1 revenue $575.6M (+22.1%), adj. EBITDA $63.3M (+36.3%); raises FY guidance
Total Revenue $575.6M, up 22.1% YoY; Adjusted EBITDA $63.3M, up 36.3% YoY.
RadNet acquires Gleamer for up to €230M; DeepHealth becomes largest radiology AI provider
All-cash deal includes ~€215M closing payment and up to €15M milestone-based contingent payment.
RadNet Q4 revenue $547.7M record; Adj. EBITDA $87.7M record; issues 17-22% growth guide for 2026
Q4 2025 revenue $547.7M (+14.8% YoY); Adj. EBITDA $87.7M (+16.9% YoY) - both quarterly records.
RadNet registers 190,924 shares for resale by Cimar Sellers as acquisition consideration
Registration covers up to 190,924 shares of common stock for resale by Cimar Sellers.
RadNet promotes four senior leaders to expanded executive roles; sets new salaries
Stephen Forthuber promoted to President and CEO, Eastern Operations; annual base salary $950,000.
RadNet files shelf registration and resale prospectus for 73,567 shares
Filed Form S-3 shelf registration statement (File No. 333-291945) to maintain an effective shelf.
RadNet Q3 revenue $522.9M (+13.4% YoY), adj. EBITDA $84.9M (+15.2%), raises FY2025 guidance
Total revenue $522.9M vs $461.1M a year ago; adjusted EPS $0.20 (up from $0.18).
RadNet files prospectus supplement to register 59,444 shares for resale by selling stockholders
Prospectus supplement filed on October 21, 2025, to register up to 59,444 shares of common stock for resale.
RadNet Q2 revenue $498.2M (+8.4% YoY), record Adj. EBITDA $81.2M; raises FY2025 guidance
Q2 revenue $498.2M (+8.4% YoY), Adjusted EBITDA $81.2M (record, +12.3%), margin up 57bps to 16.3%.
RadNet completes iCAD acquisition via DeepHealth subsidiary; expands AI breast health
DeepHealth, RadNet's digital health segment, closed acquisition of iCAD (NASDAQ: ICAD).
RadNet secures $100M incremental term loan for acquisitions; shareholder votes routine
Incremental term loan of $100M from Barclays; matures April 18, 2031, same as existing $868.4M loan.
RadNet Q1 revenue up 9.2% to $471M, net loss $37.9M; raises 2025 revenue and EBITDA guidance
Revenue $471.4M (+9.2% YoY); Adjusted EBITDA $46.4M (-20.6% YoY) hit by $22M revenue and $15M EBITDA from SoCal wildfires and winter weather.
RadNet to acquire iCAD for ~$103M all-stock; ~98% premium
All-stock acquisition of iCAD for ~$103M (0.0677 RDNT shares per ICAD share); ~98% premium to ICAD's April 14 close.
RadNet Q4 revenue $477M (+13.5%), Adj EBITDA $75M record; FY2025 guidance issued
Q4 revenue $477.1M (+13.5% y/y), Adjusted EBITDA $75.0M (+14.0%), both quarterly records.
RadNet amends credit facility, reducing interest rates by 0.25% on $872.8M term loans
Interest rate on term loans reduced to Term SOFR + 2.25% or base rate + 1.25%.
RadNet reports record Q3 revenue $461.1M (+14.7%), raises 2024 guidance
Revenue $461.1M (+14.7% YoY); Adj. EBITDA $73.7M (+27.2%); adjusted EPS $0.18 vs $0.13.
RadNet Digital Health segment revenue up 34% in H1 2024; AI revenue grows 128% YoY
Full-year Digital Health revenue guidance of $60-70M with adjusted EBITDA of $13-15M.
RadNet appoints Kees Wesdorp as President & CEO of Digital Health segment effective Oct 1, 2024
Wesdorp will lead eRAD, DeepHealth OS and AI solutions under the Digital Health division.
RadNet Q2 revenue $459.7M (+13.9% YoY), adj. EBITDA $72.3M (+19.7%), raises FY2024 guidance
Adjusted diluted EPS $0.16 vs $0.10 YoY; GAAP net loss $3.0M due to $8.8M debt refinancing costs.
RadNet stockholders elect seven directors, ratify auditor, approve say-on-pay at annual meeting
Quorum of 66,080,565 shares (89.42% of outstanding) represented at the meeting.
RadNet Q1 revenue $431.7M (+10.5% YoY); adjusted EBITDA $58.5M (+21.4%); raises 2024 guidance
Q1 net loss $(0.04)/share vs $(0.36) last year; adjusted EPS $0.07 vs $(0.22).
RadNet closes $875M term loan and $282M revolver refinancing, extends maturities
New $875M senior secured term loan matures April 2031; revolver of $282M matures April 2029.
RadNet prices $875M term loan and $282M revolver in upsized refinancing
$875M term loan (up from $840M) at SOFR+2.50%, 7-yr maturity; $282M revolver (up from $250M), 5-yr term.
RadNet proposes $840M term loan and $250M revolver to refinance existing debt, add $148M for growth
RadNet plans $840M term loan (7-yr) and $250M revolver (5-yr), replacing $679M due 2028 and $195M due 2026.
RadNet closes $230.2M common stock offering (5.23M shares at $44.00/share)
Closed public offering of 5,232,500 shares at $44.00/share, including full exercise of underwriters' option for 682,500 additional shares.
RadNet Q4 revenue record $420.4M (+9.5%), Adj. EBITDA $65.8M (+15%); guides 2024 higher
Q4 revenue $420.4M (+9.5% YoY); Imaging Center revenue $415.3M (+8.6%); total Adj. EBITDA $65.8M (+15%)
On September 11, 2024 RadNet, Inc. (“RadNet”) appointed Cornelis “Kees” Wesdorp, age 47, to serve as President and Chief Executive Officer of its Digital Health segment (“Digital Health”), which includes RadNet’s eRad and Artificial Intelligence businesses, effective October 1, 2024.
Max materiality 0.85 · Median 0.70 · Most common event earnings